HZNP

Horizon Therapeutics Public Limited Company Ordinary Shares

Delisted

HZNP was delisted on the 5th of October, 2023.

232 hedge funds and large institutions have $2.54B invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2016 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 73 increasing their positions, 70 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

10% more capital invested

Capital invested by funds: $2.31B → $2.54B (+$224M)

4% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 70

Holders
232
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$155M
Puts
$44.9M
Net Calls
Net Calls Change

Top Buyers

1 +$77.1M
2 +$67.1M
3 +$50.1M
4
GT
Glenmede Trust
Pennsylvania
+$37.2M
5
Goldman Sachs
Goldman Sachs
New York
+$34M

Top Sellers

1 -$192M
2 -$132M
3 -$57.8M
4
TCM
TimesSquare Capital Management
New York
-$26.3M
5
BC
Broadfin Capital
New York
-$24.7M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$232M
2
$216M
3
$128M
4
$124M
5
$117M
6
$99.8M
7
$78.3M
8
$77.1M
9
$76.8M
10
$73.6M
11
$69.2M
12
$67.1M
13
$48M
14
$43.7M
15
$38.2M
16
$37.8M
17
$37.2M
18
$35.6M
19
$34.9M
20
$31M
21
$30.9M
22
$30.4M
23
$26.7M
24
$26.5M
25
$25.9M